The ways in which we treat diseases are becoming more and more innovative, with the biotech industry demonstrating its full potential in the development of new ways to treat patients. Collaboration among industry, academia, regulatory, clinician and patient communities, as well as ad hoc funding and investment frameworks are essential to bring these solutions to the patients.
At this years conference PROXIDRUGS speaker Ivan Đikić presented a talk about “PROXIDRUGS: new therapeutic options for numerous diseases”.
